EGFR and neoplasm: Our analysis of this dataset revealed that both HBEGF and the monocytic marker CD64 are predominantly expressed in the stromal compartment (Additional file 1: Figure S10A), suggesting that tumor-associated mononuclear cells express this EGFR agonist.